Home › Funds › Patient Square Capital LP › ROIV

Patient Square Capital LP position in ROIV

ROIVANT SCIENCES LTD · Health Care

Patient Square Capital LP reported holding 7,710,928 shares of ROIV (ROIVANT SCIENCES LTD) in its Q3 2026 13F filing — a position valued at US$282.0M, representing 45.00% of its reported portfolio and ranking #1 among its reported holdings. Patient Square Capital LP has disclosed ROIV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)7.71M sh
Reported value held$281.99M
Portfolio Weight45.00%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Patient Square Capital LP's ROIV position evolved

Patient Square Capital LP first disclosed a stake in ROIV in Q3 2023 at 12,639,920 shares (US$147.6M). The position peaked in Q2 2026 at 8,020,928 shares, worth US$283.9M. Across 13 filings, Patient Square Capital LP increased the stake 1 time(s), trimmed it 4 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 7,710,928 shares valued at US$282.0M — a reduction of -310,000 shares quarter over quarter.. Notable position changes include a 35% trim in Q4 2025 (shares rose 28% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 12.64M $147.63M New
Q4 2023 12.64M $141.95M Hold
Q1 2024 12.23M $128.89M Reduce
Q2 2024 12.23M $129.25M Hold
Q3 2024 12.23M $141.12M Hold
Q4 2024 12.48M $147.64M Add
Q1 2025 12.48M $125.92M Hold
Q2 2025 12.48M $140.65M Hold
Q3 2025 12.48M $188.82M Hold
Q4 2025 8.17M $177.20M Reduce
Q1 2026 8.17M $226.20M Hold
Q2 2026 8.02M $283.86M Reduce
Q3 2026 7.71M $281.99M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ROIV and 13F data

ROIV (ROIVANT SCIENCES LTD) is a Health Care company. 61 other funds we track also report a position in ROIV — the largest reported positions include QVT Financial LP (US$839.6M), Farallon Capital Management (US$506.4M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$506.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ROIV

All ROIV fund holders →

FAQ

How long has Patient Square Capital LP held ROIV?

Patient Square Capital LP has disclosed ROIV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Patient Square Capital LP's current position in ROIV?

As of Q3 2026, Patient Square Capital LP holds 7.71M shares of ROIV (ROIVANT SCIENCES LTD), valued at $281.99M, representing 45.00% of its reported portfolio and ranking #1.

Has Patient Square Capital LP been buying or selling ROIV?

In the latest 13F filing (Q3 2026), Patient Square Capital LP reduced its position in ROIV. The position peaked in Q2 2026 at 8.02M shares.

Which other funds hold ROIV?

Other major institutional holders of ROIV include QVT Financial LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 61 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.